Home Biosimilar Antibodies Immunology & Inflammation IL Receptor antibody Tozorakimab (Anti-IL-33) For research use only.
Not for use in humans.

Tozorakimab (Anti-IL-33)

Synonyms: MEDI-3506

Tozorakimab (Anti-IL-33) is a human immunoglobulin G1 monoclonal antibody targeting interleukin-33. It can be used to research chronic obstructive pulmonary disease. MW :144.54 KD.

Tozorakimab (Anti-IL-33)

Purity & Quality Control

Batch: Purity: 99% Protein concentration: 8mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective IL Receptor Inhibitors

Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Tozorakimab (Anti-IL-33) is a human immunoglobulin G1 monoclonal antibody targeting interleukin-33. It can be used to research chronic obstructive pulmonary disease. MW :144.54 KD.

Product Details

CAS No. 2376858-66-9
Isotype Human IgG1
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Tozorakimab (Anti-IL-33) | Tozorakimab (Anti-IL-33) supplier | purchase Tozorakimab (Anti-IL-33) | Tozorakimab (Anti-IL-33) cost | Tozorakimab (Anti-IL-33) manufacturer | order Tozorakimab (Anti-IL-33) | Tozorakimab (Anti-IL-33) distributor